AstraZeneca Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Date | Value | Name | Entity | Role | Shares | Max Price |
---|---|---|---|---|---|---|
22 Nov 23 | Buy€233,122 | Michel Demare | Individual | 2,000 | €116.61 |
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Individual Insiders | 729,365 | 0.047% |
Public Companies | 777,613 | 0.0502% |
Private Companies | 1,892,363 | 0.122% |
State or Government | 2,368,774 | 0.153% |
General Public | 430,781,774 | 27.8% |
Institutions | 1,113,681,195 | 71.8% |
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
132,015,351 | €18.6b | -1.89% | 0.36% | |||
113,047,040 | €15.9b | -1.23% | 1.02% | |||
67,155,711 | €9.5b | 1.34% | 0.18% | |||
57,587,700 | €8.1b | -0.49% | 1.82% | |||
51,587,810 | €7.3b | 0% | 11.98% | |||
34,644,764 | €4.9b | 0.25% | 0.46% | |||
27,320,760 | €3.8b | 0.09% | 0.69% | |||
26,175,035 | €3.7b | 1.26% | 0.81% | |||
25,821,555 | €3.6b | -0.11% | 0.32% | |||
25,458,559 | €3.6b | 0.03% | 0.16% | |||
19,095,678 | €2.7b | -0.83% | 3.42% | |||
18,900,643 | €2.7b | 5.04% | 0.43% | |||
16,842,855 | €2.4b | 19.4% | 0.55% | |||
16,581,230 | €2.3b | 1.44% | 1.33% | |||
13,616,076 | €1.9b | -4.96% | 1.33% | |||
12,530,044 | €1.8b | -1.13% | 0.24% | |||
12,284,525 | €1.7b | 6.96% | 2.64% | |||
11,386,858 | €1.6b | -0.16% | 2.22% | |||
10,213,248 | €1.4b | -3.22% | 1.24% | |||
9,330,068 | €1.3b | -1.86% | 0.66% | |||
9,262,615 | €1.3b | -0.14% | 0.26% | |||
8,690,208 | €1.2b | 0.82% | 0.4% | |||
8,486,821 | €1.2b | -4.15% | 0.37% | |||
7,765,802 | €1.1b | 2.15% | 0.35% | |||
7,323,603 | €1.0b | 3.05% | 0.09% |